0 NYSE Companies - February 13, 2019Vornado Completes $580 Million Refinancing of 100 West 33rd StreetNEW YORK, Feb. 13, 2019 (GLOBE NEWSWIRE) — VORNADO REALTY TRUST (NYSE: VNO) announced today that it has completed a […]Read More
0 NYSE Companies - February 13, 2019Laredo Petroleum Announces 2018 Fourth-Quarter and Full-Year Financial and Operating ResultsTULSA, OK., Feb. 13, 2019 (GLOBE NEWSWIRE) — Laredo Petroleum, Inc. (NYSE: LPI) (“Laredo” or the “Company”) today announced its […]Read More
0 NYSE Companies - February 13, 2019Carriage Services Announces 2018 Annual Results Earnings Release and Conference Call ScheduleHOUSTON, Feb. 13, 2019 (GLOBE NEWSWIRE) — Carriage Services, Inc. (NYSE: CSV) today announced plans to release 2018 annual results […]Read More
0 NYSE Companies - February 13, 2019ADT to Release Fourth Quarter and Full Year 2018 Earnings on Monday, March 11, 2019BOCA RATON, Fla., Feb. 13, 2019 (GLOBE NEWSWIRE) — ADT Inc. (NYSE: ADT) will release its fourth quarter and full […]Read More
0 NYSE Companies - February 13, 2019Apollo Commercial Real Estate Finance, Inc. Reports Fourth Quarter and Full Year 2018 Financial ResultsNEW YORK, Feb. 13, 2019 (GLOBE NEWSWIRE) — Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE:ARI) today […]Read More
0 NYSE Companies - February 13, 2019Kadant Reports Fourth Quarter and Fiscal Year 2018 ResultsRecord Revenue, Bookings and Diluted EPS in FY 2018 WESTFORD, Mass., Feb. 13, 2019 (GLOBE NEWSWIRE) — Kadant Inc. (NYSE: KAI) […]Read More
0 NYSE Companies - February 13, 2019Kadant Announces CEO Succession PlanWESTFORD, Mass., Feb. 13, 2019 (GLOBE NEWSWIRE) — Kadant Inc. (NYSE: KAI) today announced that Jeffrey L. Powell will be […]Read More
0 NYSE Companies - February 13, 2019Novartis receives FDA approval for Egaten® for the treatment of fascioliasis, a neglected tropical diseaseEgaten is the only drug approved in the US for the treatment of people with fascioliasis and is currently the […]Read More
0 NYSE Companies - February 13, 2019GNC Receives Full Funding of $300 Million Investment by Harbin Pharmaceutical GroupCloses on Final $150 Million Investment Enhances GNC Capital Position PITTSBURGH, Feb. 13, 2019 (GLOBE NEWSWIRE) — GNC Holdings, Inc. […]Read More
0 NYSE Companies - February 13, 2019DeLoach to Retire as Executive Chairman of Sonoco; Haley Named Chairman-elect of Board of DirectorsHARTSVILLE, S.C., Feb. 13, 2019 (GLOBE NEWSWIRE) — Sonoco (NYSE: SON), one of the largest diversified global packaging companies, today […]Read More